% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/gbsg.R
\docType{data}
\name{gbsg}
\alias{gbsg}
\title{Breast cancer data sets used in Royston and Altman (2013)}
\format{
A data frame with 686 rows and 11 variables:
\describe{
\item{\code{pid}}{Patient identifier}
\item{\code{age}}{Age, years}
\item{\code{meno}}{Menopausal status (0=premenopausal, 1=postmenopausal)}
\item{\code{size}}{Tumor size, mm}
\item{\code{grade}}{Tumor grade}
\item{\code{nodes}}{The number of positive lymph nodes}
\item{\code{pgr}}{Progesterone receptors (fmol/l)}
\item{\code{er}}{Estrogen receptors (fmol/l)}
\item{\code{hormon}}{Hormonal therapy, 0=no, 1=yes}
\item{\code{rfstime}}{Recurrence free survival time; days to first of reccurence, death or last follow-up}
\item{\code{status}}{Censoring indicator, 0=alive without recurrence, 1=recurrence or death}
}
}
\source{
\code{\link[survival]{gbsg}} in \code{survival} package
}
\usage{
gbsg
}
\description{
The \code{gbsg} data set contains patient records from a 1984-1989 trial conducted by the German Breast Cancer Study Group (GBSG) of 720 patients
with node positive breast cancer; it retains the 686 patients with complete data for the prognostic variables.
}
\details{
These data sets are used in the paper by Royston and Altman (2013). The Rotterdam data is used to create a fitted model,
and the GBSG data for validation of the model. The paper gives references for the data source.
}
\references{
Royston P, Altman DG (2013): External validation of a Cox prognostic model: principles and methods.
\emph{BMC Med Res Methodol}. DOI: 10.1186/1471-2288-13-33.

.
}
\keyword{datasets}
